Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04216238 · ClinicalTrials.gov registry record
Association of Wearable Activity Monitors With Post-Operative Activity Level Among Cardiovascular Surgical Patients
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 12
- Enrollment target
NCT04216238: Completed study, sponsored by Methodist Health System.
NCT04216238 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04216238 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Early mobility in the post cardiovascular surgical patient can dramatically impact patient outcomes. Utilizing an innovative strategy, like a wearable activity monitor, can potentially provide: accurate data on post-operative mobility level; increased motivation and self-efficacy in the recovering patient; data to potentially drive post-operative mobility goal setting. Use of a wearable activity monitor will reduce time needed to return to pre-operative activity level in the cardiovascular surgical patient.
Primary Outcome
refers to behavior that is driven by internal rewards. In other words, the motivation to engage in a behavior arises from within the individual because it is naturally satisfying.
Interventions
- BEHAVIORAL quasi-experimental Pre-test/Post-test design
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-08-13 |
| Est. Completion | 2022-05-24 |
What the finished NCT04216238 record still lists
NCT04216238 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which quasi-experimental Pre-test/Post-test design is the first listed.
NCT04216238 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04216238 about?
NCT04216238 is a clinical study titled "Association of Wearable Activity Monitors With Post-Operative Activity Level Among Cardiovascular Surgical Patients". Early mobility in the post cardiovascular surgical patient can dramatically impact patient outcomes. Utilizing an innovative strategy, like a wearable activity monitor, can potentially provide: accurate data on post-operative mobility level; increased motivation and self-efficacy in the recovering p...
What is the current status of trial NCT04216238?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2019-08-13. Estimated completion is 2022-05-24.
What interventions are being tested in trial NCT04216238?
The interventions under investigation include: quasi-experimental Pre-test/Post-test design (BEHAVIORAL).
Who is sponsoring clinical trial NCT04216238?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI